Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery

Pulin Che, Long Cui, Olaf Kutsch, Liwang Cui, Qianjun Li

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

The emergence and spread of multidrug-resistant Plasmodium falciparum and recent detection of potential artemisinin-resistant strains in Southeast Asia highlight the importance of developing novel antimalarial therapies. Using a previously generated stable transgenic P. falciparum line with high-level firefly luciferase expression, we report the adaptation, miniaturization, optimization, and validation of a high-throughput screening assay in 384-well plates. Assay conditions, including the percentage of parasitemia and hematocrit, were optimized. Parameters of assay robustness, including Z′-value, coefficient variation (CV), and signal-to-background (S/B) ratio, were determined. The LOPAC 1280 small-compound library was used to validate this assay. Our results demonstrated that this assay is robust and reliable, with an average Z′-value of >0.7 and CV of <10%. Moreover, this assay showed a very low background, with the S/B ratio up to 71. Further, identified hits were selected and confirmed using a SYBR Green I-based confirmatory assay. It is evident that this assay is suitable for large-scale screening of chemical libraries for antimalarial drug discovery.

Original languageEnglish (US)
Pages (from-to)61-68
Number of pages8
JournalAssay and Drug Development Technologies
Volume10
Issue number1
DOIs
StatePublished - Feb 1 2012

Fingerprint

High-Throughput Screening Assays
Firefly Luciferases
Antimalarials
Drug Discovery
Plasmodium falciparum
Small Molecule Libraries
Miniaturization
Southeastern Asia
Parasitemia
Hematocrit
Libraries
Therapeutics
artemisinine
SYBR Green I

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Drug Discovery

Cite this

Che, Pulin ; Cui, Long ; Kutsch, Olaf ; Cui, Liwang ; Li, Qianjun. / Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. In: Assay and Drug Development Technologies. 2012 ; Vol. 10, No. 1. pp. 61-68.
@article{8f1b1b8eed4d44728721e436aa79c4ae,
title = "Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery",
abstract = "The emergence and spread of multidrug-resistant Plasmodium falciparum and recent detection of potential artemisinin-resistant strains in Southeast Asia highlight the importance of developing novel antimalarial therapies. Using a previously generated stable transgenic P. falciparum line with high-level firefly luciferase expression, we report the adaptation, miniaturization, optimization, and validation of a high-throughput screening assay in 384-well plates. Assay conditions, including the percentage of parasitemia and hematocrit, were optimized. Parameters of assay robustness, including Z′-value, coefficient variation (CV), and signal-to-background (S/B) ratio, were determined. The LOPAC 1280 small-compound library was used to validate this assay. Our results demonstrated that this assay is robust and reliable, with an average Z′-value of >0.7 and CV of <10{\%}. Moreover, this assay showed a very low background, with the S/B ratio up to 71. Further, identified hits were selected and confirmed using a SYBR Green I-based confirmatory assay. It is evident that this assay is suitable for large-scale screening of chemical libraries for antimalarial drug discovery.",
author = "Pulin Che and Long Cui and Olaf Kutsch and Liwang Cui and Qianjun Li",
year = "2012",
month = "2",
day = "1",
doi = "10.1089/adt.2011.0378",
language = "English (US)",
volume = "10",
pages = "61--68",
journal = "Assay and Drug Development Technologies",
issn = "1540-658X",
publisher = "Mary Ann Liebert Inc.",
number = "1",

}

Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery. / Che, Pulin; Cui, Long; Kutsch, Olaf; Cui, Liwang; Li, Qianjun.

In: Assay and Drug Development Technologies, Vol. 10, No. 1, 01.02.2012, p. 61-68.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Validating a firefly luciferase-based high-throughput screening assay for antimalarial drug discovery

AU - Che, Pulin

AU - Cui, Long

AU - Kutsch, Olaf

AU - Cui, Liwang

AU - Li, Qianjun

PY - 2012/2/1

Y1 - 2012/2/1

N2 - The emergence and spread of multidrug-resistant Plasmodium falciparum and recent detection of potential artemisinin-resistant strains in Southeast Asia highlight the importance of developing novel antimalarial therapies. Using a previously generated stable transgenic P. falciparum line with high-level firefly luciferase expression, we report the adaptation, miniaturization, optimization, and validation of a high-throughput screening assay in 384-well plates. Assay conditions, including the percentage of parasitemia and hematocrit, were optimized. Parameters of assay robustness, including Z′-value, coefficient variation (CV), and signal-to-background (S/B) ratio, were determined. The LOPAC 1280 small-compound library was used to validate this assay. Our results demonstrated that this assay is robust and reliable, with an average Z′-value of >0.7 and CV of <10%. Moreover, this assay showed a very low background, with the S/B ratio up to 71. Further, identified hits were selected and confirmed using a SYBR Green I-based confirmatory assay. It is evident that this assay is suitable for large-scale screening of chemical libraries for antimalarial drug discovery.

AB - The emergence and spread of multidrug-resistant Plasmodium falciparum and recent detection of potential artemisinin-resistant strains in Southeast Asia highlight the importance of developing novel antimalarial therapies. Using a previously generated stable transgenic P. falciparum line with high-level firefly luciferase expression, we report the adaptation, miniaturization, optimization, and validation of a high-throughput screening assay in 384-well plates. Assay conditions, including the percentage of parasitemia and hematocrit, were optimized. Parameters of assay robustness, including Z′-value, coefficient variation (CV), and signal-to-background (S/B) ratio, were determined. The LOPAC 1280 small-compound library was used to validate this assay. Our results demonstrated that this assay is robust and reliable, with an average Z′-value of >0.7 and CV of <10%. Moreover, this assay showed a very low background, with the S/B ratio up to 71. Further, identified hits were selected and confirmed using a SYBR Green I-based confirmatory assay. It is evident that this assay is suitable for large-scale screening of chemical libraries for antimalarial drug discovery.

UR - http://www.scopus.com/inward/record.url?scp=84863233246&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863233246&partnerID=8YFLogxK

U2 - 10.1089/adt.2011.0378

DO - 10.1089/adt.2011.0378

M3 - Article

C2 - 22050430

AN - SCOPUS:84863233246

VL - 10

SP - 61

EP - 68

JO - Assay and Drug Development Technologies

JF - Assay and Drug Development Technologies

SN - 1540-658X

IS - 1

ER -